Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celiprolol vs Diltiazem for Postoperative Arrhythmias
NCT03752931Phase 2Unknown
- Sponsor
- Abderrahmane Mami Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of celiprolol in Atrial fibrillation (AFib), sponsored by Abderrahmane Mami Hospital. Primary endpoint: Incidence of early postoperative atrial fibrillation at 14 days. Status: unknown.
02
Drugs
celiprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03752931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752931.